Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Avanir Pharmaceuticals Inc. et al v. Wockhardt Ltd. et al
Case Number:
1:11-cv-00758
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 06, 2013
Avanir Settles With Wockhart Over Planned Nuedexta Generic
Avanir Pharmaceuticals Inc. said Friday it has reached a settlement with Wockhardt Ltd. over its planned generic version of mental health drug Nuedexta, ending a patent infringement dispute in Delaware federal court.
-
August 30, 2011
Avanir Targets Wockhardt In Nuedexta Patent Blitz
Avanir Pharmaceuticals Inc. on Tuesday sued drugmaker Wockhardt Ltd. in an effort to block its plans to make a generic version of mental health drug Nuedexta, marking the latest complaint in a campaign of patent suits over the drug.